Allspring Global Investments’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-79
Closed -$887 1766
2024
Q3
$887 Sell
79
-11,179
-99% -$119K ﹤0.01% 2334
2024
Q2
$113K Buy
+11,258
New +$114K ﹤0.01% 1828
2023
Q4
Sell
-4,403
Closed -$40.1K 2222
2023
Q3
$40.1K Sell
4,403
-150,959
-97% -$1.81M ﹤0.01% 2333
2023
Q2
$1.89M Buy
155,362
+150,116
+2,862% +$1.67M ﹤0.01% 1256
2023
Q1
$65.2K Sell
5,246
-40,688
-89% -$749K ﹤0.01% 2199
2022
Q4
$883K Buy
45,934
+394
+0.9% +$8.33K ﹤0.01% 1463
2022
Q3
$855K Sell
45,540
-2,269
-5% -$46.6K ﹤0.01% 1458
2022
Q2
$862K Buy
47,809
+4,457
+10% +$72.4K ﹤0.01% 1457
2022
Q1
$694K Buy
43,352
+4,501
+12% +$80.9K ﹤0.01% 2080
2021
Q4
$950K Buy
+38,851
New +$912K ﹤0.01% 1967

Other funds holding AHCO

Allspring Global Investments's AHCO Position: Q4 2024 in Review

Allspring Global Investments sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 79 shares — an estimated $887 sold.

Allspring Global Investments first reported a position in AHCO in Q4 2021 and held it in 10 quarters. The position peaked at $1.89M in Q2 2023. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

  • Allspring Global Investments reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 79 AdaptHealth shares in Q4 2024, an estimated $887.
  • Allspring Global Investments first reported a position in AdaptHealth in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's AdaptHealth position peaked at $1.89M in Q2 2023.
  • 200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.